Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Univ CardifffiledCriticalGlaxo Group Ltd
Publication of TNSN00029A1publicationCriticalpatent/TNSN00029A1/fr
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
LA PRESENTE INVENTION PORTE SUR DES ANALOGUES DE (1R,cis)-4- (6-AMINO-9H-PURIN-9-YL)-2-CYCLOPENTENE-1-METHANOL, SUR DES PROCEDES PERMETTANT LEUR PREPARATION, ET SUR LEUR USAGE DANS LE TRAITEMENT D'INFECTIONS VIRALES.
TNTNSN00029A1999-02-122000-02-10ANALOGUES DE (1R,cis)-4-(6-AMINO-9H-PURIN-9-YL)-2- CYCLOPENTENE-1-METHANOL COMME AGENTS ANTIVIRAUX
TNSN00029A1
(fr)
Utilisation de compositions contenant des formes solubles d'hla-g dans le traitement de pathologies inflammatoires de la peau, et leur procede d'obtention
Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы